Kairos Pharma Ltd (AMEX:KAPA) does about 2.13M shares in volume on a normal day but saw 2864392 shares change hands in the recent trading day. The company now has a market cap of 19.40M USD. Its current market price is $1.51, marking a decrease of -29.11% compared to the previous close of $2.13. The 52 week high reached by this stock is $4.00 whilst the lowest price level in 52 weeks is $0.85.
Kairos Pharma Ltd (KAPA) has a 20-day trading average at $1.58 and the current price is -62.25% off the 52-week high compared with 77.44% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.57. If we look at the stock’s price movements over the week, volatility stands at 67.76%, which decreases to 23.82% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 49.08 to suggest the stock is neutral.
The consensus objective for the share price is $10.50, suggesting that the stock has a potential upside of 85.62% over the period.
The current price level is -4.37%, -3.75%, and -5.32% away from its SMA20, SMA50, and SMA200 respectively, with the KAPA price moving above the 50-day SMA on current market day. Kairos Pharma Ltd (KAPA) stock is down -3.82% over the week and -9.04% over the past month. Its price is -0.66% year-to-date.
The company’s next earnings report forecasts estimating quarterly EPS at -0.02 and -0.1 for whole year.
To reach the target analysts have set, the stock logically needs to grow 85.62 percent from here.
Outstanding shares total 12.85M with insiders holding 68.83% of the shares and institutional holders owning 0.10% of the company’s common stock. The company has a return on investment of -82.26% and return on equity of -375.74%. Price to book ratio is 5.82.
